All In MedTech

Device Trial Radar · NCT03056222

CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Nov 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

360

Actual

Start

Apr 10, 2017

Primary completion

Aug 16, 2021

Study completion Nov 15, 2021

Sponsor

Lead sponsor
I-Med-Pro GmbHAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 17, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of the study is to compare the acute procedure and safety outcomes as well as long term clinical outcomes of 2 groups of patients treated with the HeartLight® Endoscopically Guided Laser Ablation (EGLA) or a commercially available Contact Force Sensing Irrigated Radiofrequency (RF) Ablation Catheter plus, at the operator's discretion, 3D Electroanatomical Mapping (EAM) for the treatment of Paroxysmal Atrial Fibrillation (PAF).

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

  • Ablation catheterDevice

    Ablation of paroxysmal atrial fibrillation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from symptomatic, recurrent atrial fibrillation (AF) off of anti-arrhythmic drugsTime frame: 12 months post procedure

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • Hartcentrum OLV Aalst

    Aalst, Belgium

  • Hartcentrum Hasselt Jessa Ziekenhuis

    Hasselt, Belgium

  • Nemocnice Na Homolce

    Prague, Czechia

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.